Extended Oral Antibiotic Prophylaxis After Aseptic Revision Total Hip Arthroplasty: Does It Decrease Infection Risk?

被引:11
作者
Bukowski, Brandon R. [1 ]
Owen, Aaron R. [1 ]
Turner, Travis W. [1 ]
Fruth, Kristin M. [2 ]
Osmon, Douglas R. [3 ]
Pagnano, Mark W. [1 ]
Berry, Daniel J. [1 ]
Abdel, Matthew P. [1 ]
机构
[1] Mayo Clin, Dept Orthoped Surg, 200 First Street SW, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Hlth Sci Res, Quantitat Hlth Sci, Rochester, MN 55905 USA
[3] Mayo Clin, Dept Med, Div Infect Dis, Rochester, MN 55905 USA
关键词
revision total hip arthroplasty (THA); periprosthetic joint infection (PJI); aseptic revision; infection; extended oral antibiotic prophylaxis; PERIPROSTHETIC JOINT INFECTION; KNEE ARTHROPLASTY; MARK COVENTRY; EPIDEMIOLOGY; MULTICENTER; FAILURE; REDUCE;
D O I
10.1016/j.arth.2022.06.023
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background: Extended oral antibiotic prophylaxis (EOA) has been shown to reduce infection after high -risk primary total hip arthroplasties (THAs) and reimplantations. However, data are limited regarding EOA after aseptic revision THAs. This study evaluated the impact of EOA on infection-related outcomes after aseptic revision THAs.Methods: We retrospectively identified 1,107 aseptic revision THAs performed between 2014 and 2019. Patients who received EOA >24 hours perioperatively (n = 370) were compared to those who did not (n = 737) using an inverse probability of treatment weighting model. Their mean age was 65 years (range, 19-98 years), mean body mass index was 30 kg/m2 (range, 16-72), and 54% were women. Out-comes included cumulative probabilities of any infection, periprosthetic joint infection (PJI), and re -revision or reoperation for infection. Mean follow-up was 4 years (range, 2-8 years).Results: The cumulative probability of any infection after aseptic revision THA was 2.3% at 90 days, 2.7% at 1 year, and 3.5% at 5 years. The cumulative probability of PJI was 1.7% at 90 days, 2.1% at 1 year, and 2.8% at 5 years. There was a trend toward an increased risk of any infection (hazards ratio [HR] = 2.6; P = .058), PJI (HR = 2.6; P = .085), and re-revision (HR = 6.5; P =.077) or reoperation (HR = 2.3; P =.095) for infection in patients who did not have EOA at the final clinical follow-up.Conclusions: EOA after aseptic revision THA was not associated with a statistically significant decreased risk of any infection, PJI, or re-revision or reoperation for infection at all time points.Level of Evidence: Level III.(c) 2022 Elsevier Inc. All rights reserved.
引用
收藏
页码:2460 / 2465
页数:6
相关论文
共 23 条
  • [1] Berry DJ, 1997, CLIN ORTHOP RELAT R, P61
  • [2] Short-term Complications After Revision Hip Arthroplasty for Prosthetic Joint Infection Are Increased Relative to Noninfectious Revisions
    Boddapati, Venkat
    Fu, Michael C.
    Tetreault, Matthew W.
    Blevins, Jason L.
    Richardson, Shawn S.
    Su, Edwin P.
    [J]. JOURNAL OF ARTHROPLASTY, 2018, 33 (09) : 2997 - 3002
  • [3] The Epidemiology of Revision Total Hip Arthroplasty in the United States
    Bozic, Kevin J.
    Kurtz, Steven M.
    Lau, Edmund
    Ong, Kevin
    Vail, Thomas P.
    Berry, Daniel J.
    [J]. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2009, 91A (01) : 128 - 133
  • [4] Bukowski BR, 2022, J ARTHROPLASTY, V37, P1
  • [5] Do Extended Oral Postoperative Antibiotics Prevent Early Periprosthetic Joint Infection in Morbidly Obese Patients Undergoing Primary Total Joint Arthroplasty?
    Carender, Christopher N.
    DeMik, David E.
    Glass, Natalie A.
    Noiseux, Nicolas O.
    Brown, Timothy S.
    Bedard, Nicholas A.
    [J]. JOURNAL OF ARTHROPLASTY, 2021, 36 (08) : 2716 - 2721
  • [6] A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION
    CHARLSON, ME
    POMPEI, P
    ALES, KL
    MACKENZIE, CR
    [J]. JOURNAL OF CHRONIC DISEASES, 1987, 40 (05): : 373 - 383
  • [7] The Mark Coventry, MD, Award: Oral Antibiotics Reduce Reinfection After Two-Stage Exchange: A Multicenter, Randomized Controlled Trial
    Frank, Jonathan M.
    Kayupov, Erdan
    Moric, Mario
    Segreti, John
    Hansen, Erik
    Hartman, Curtis
    Okroj, Kamil
    Belden, Katherine
    Roslund, Brian
    Silibovsky, Randi
    Parvizi, Javad
    Della Valle, Craig J.
    [J]. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2017, 475 (01) : 56 - 61
  • [8] The Lawrence D. Dorr Surgical Techniques & Technologies Award: Why Are Contemporary Revision Total Hip Arthroplasties Failing? An Analysis of 2500 Cases
    Goldman, Ashton H.
    Sierra, Rafael J.
    Trousdale, Robert T.
    Lewallen, David G.
    Berry, Daniel J.
    Abdel, Matthew P.
    [J]. JOURNAL OF ARTHROPLASTY, 2019, 34 (07) : S11 - S16
  • [9] Current Epidemiology of Revision Total Hip Arthroplasty in the United States: National Inpatient Sample 2009 to 2013
    Gwam, Chukwuweike U.
    Mistry, Jaydev B.
    Mohamed, Nequesha S.
    Thomas, Melbin
    Bigart, Kevin C.
    Mont, Michael A.
    Delanois, Ronald E.
    [J]. JOURNAL OF ARTHROPLASTY, 2017, 32 (07) : 2088 - 2092
  • [10] Extended Oral Antibiotic Prophylaxis in High-Risk Patients Substantially Reduces Primary Total Hip and Knee Arthroplasty 90-Day Infection Rate
    Inabathula, Avinash
    Dilley, Julian E.
    Ziemba-Davis, Mary
    Warth, Lucian C.
    Azzam, Khalid A.
    Ireland, Philip H.
    Meneghini, R. Michael
    [J]. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2018, 100 (24) : 2103 - 2109